The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers

Purpose of ReviewTo characterize and interpret recent studies of biomarkers of cardiorenal syndrome.Recent FindingsRecent studies have questioned the mechanisms and significance of moderate worsening renal function (WRF) in patients with acute heart failure. In the setting of successful decongestion, WRF may not predict cardiorenal morbidity. Cardiac-specific biomarkers including cardiac troponins and natriuretic peptides are highly prognostic in acute and chronic HF patients with kidney impairment, and serial changes in these markers during hospitalization are also predictive of longer-term adverse outcomes. These markers also predict new HF in patients with established chronic kidney disease (CKD). The role of kidney tubular injury markers in acute HF remains controversial, with inconsistent associations with short- and long-term cardiorenal outcomes. Many cases of WRF in acute HF are not characterized by a clear pattern of renal tubular injury.SummaryCardiac-specific and renal-specific biomarkers may provide mechanistic and prognostic information in cardiorenal syndromes.